VocaVibe

AI-diagnosis and Monitoring of Parkinson’s disease Using Voice

Health Tech & Life Sciences
Active
Pre-Seed Modi'in-Maccabim-Re'ut Founded 2023
Website ↗
Total raised
$1.0M
Last: Pre-Seed 2023-06
Stage
Pre-Seed
Founded
2023
Headcount
5
HQ
Modi'in-Maccabim-Re'ut
Sector
Health Tech & Life Sciences

About

VocaVibe is set to become the preferred choice for Parkinson's disease (PD) management by offering non-invasive, AI-driven diagnostics through vocal biomarkers. This technology provides early and accurate diagnosis, enabling continuous and real-time monitoring of disease progression and treatment efficacy. By improving patient management and allowing for effortless remote assessments, VocaVibe significantly enhances patient quality of life. It also reduces healthcare costs by minimizing hospital visits and preventing complications through timely interventions. Our strategic partnerships and proven clinical results further establish VocaVibe as the future standard of care in PD management.

Funding history · 1 round · $1.0M total

2023-06
Pre-Seed $1.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical WorkflowMedical Decision SupportPatient Remote MonitoringDigital Medical Diagnostics
Technologies
Artificial IntelligenceDeep LearningVoice & Speech RecognitionNatural Language ProcessingMachine LearningSensingAcoustics
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsInsurance Companies
Business model
B2BB2B2C

Highlights

Verified